Molecular Pro-Apoptotic Activities of Flavanone Derivatives in Cyclodextrin Complexes: New Implications for

Angelika A Adamus-Grabicka1, Pawel Hikisz2, Artur Stepniak3

  • 1Department of Bioinorganic Chemistry, Faculty of Pharmacy, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.

Insights

This study reveals that flavanone and chromanone derivatives, particularly their spiro-1-pyrazoline forms, exhibit significant anticancer activity. Reactive oxygen species (ROS) play a key role in their pro-apoptotic effects and cytotoxicity.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Biochemistry

Background:

  • Flavanones, chromanones, and their spiro-1-pyrazoline derivatives are classes of compounds with potential biological activities.
  • Understanding the molecular mechanisms underlying their antiproliferative effects is crucial for drug development.

Purpose of the Study:

  • To evaluate the antiproliferative potential of flavanones, chromanones, and their spiro-1-pyrazoline derivatives and inclusion complexes.
  • To elucidate the role of reactive oxygen species (ROS) in the cytotoxic and pro-apoptotic activities of these compounds.
  • To assess the impact of these compounds on coagulation pathways and red blood cells (RBCs).

Main Methods:

  • Analysis of mitochondrial potential and necrotic/apoptotic cell fractions.
  • Utilizing fluorescent probes to detect reactive oxygen species (ROS) generation.
  • Assays for thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (APTT), hemolysis, and microscopy studies on RBCs.

Main Results:

  • Reactive oxygen species (ROS) generation significantly contributes to the anticancer activity of flavanone analogue complexes.
  • The study analyzed the effects on mitochondrial potential and cell death pathways (apoptosis/necrosis).
  • The influence on coagulation parameters (TT, PT, APTT) and red blood cell integrity was evaluated.

Conclusions:

  • Flavanone and chromanone derivatives, especially spiro-1-pyrazoline conjugates, possess significant antiproliferative and pro-apoptotic potential.
  • Reactive oxygen species (ROS) are key mediators of their anticancer effects.
  • Further investigation into their safety profile concerning coagulation and RBCs is warranted.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K